2025 年全球止血药市场报告

预计未来几年止血剂的市场规模将强劲成长。到 2029 年，这一数字将成长至 46.7 亿美元，复合年增长率为 6.8%。预测期内的成长可归因于紧急准备和大流行应对、全球医疗保健基础设施的发展、对微创手术的需求不断增长、各个专业的应用不断扩大以及对生物相容性的重视。预测期内的主要趋势包括产品创新、止血技术的进步以及对微创手术的关注。

预计外科手术的增加将推动止血材料市场未来的成长。外科手术是指对人体采取任何形式的侵入性治疗，以检查或治疗病理状况。止血钳在外科手术过程中必不可少，因为它们用于防止手术期间出血。例如，根据总部位于黎巴嫩的整形外科医生专业组织国际美容整形外科学会 2023 年 9 月的报告，2022 年整形外科医生执行的手术总体增长了 11.2%，全球共执行了超过 1490 万例手术和超过 1880 万例非手术手术。此外，自上次调查以来，手术和非手术治疗均有所增加（分别为 16.7% 和 7.2%）。因此，外科手术的增加正在推动止血材料市场的成长。

由于政府推出免费手术的倡议，止血材料市场预计将进一步成长。免费手术不向患者收取任何费用，减轻了经济困难患者的治疗负担。根据 PubMed 2022 年 5 月的一篇报导报道，在印度各地三级医院进行的一项研究显示了显着的影响。约41.7%的受访者平等地进行了腹腔镜和开放性手术，展示了止血材料的多样化应用。手术需求的激增，尤其是止血材料使用的趋势，凸显了政府措施在推动止血材料市场成长方面的关键作用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球止血剂市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球止血剂市场：成长率分析
• 全球止血剂市场表现：规模与成长，2019 年至 2024 年
• 全球止血剂市场预测：2024-2029 年、2034 年规模与成长
• 止血钳的全球总潜在市场 (TAM)

第六章 市场细分

• 全球止血剂市场类型、性能及预测，2019-2024、2024-2029、2034
• 凝血酶类止血剂
• 氧化再生纤维素基止血剂
• 复合止血钳
• 明胶基止血材料
• 胶原蛋白基止血材料
• 全球止血剂市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 主动止血剂
• 被动止血
• 复合止血钳
• 其他产品
• 全球止血剂市场：按配方、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 基质和凝胶止血剂
• 止血片和垫片
• 海绵止血材料
• 粉末止血剂
• 全球止血剂市场应用、效能及预测，2019-2024、2024-2029、2034
• 整形外科
• 一般外科
• 神经外科
• 心血管外科
• 重组手术
• 妇科手术
• 其他用途
• 全球止血剂市场：凝血酶类止血剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 局部凝血酶
• 冷冻干燥凝血酶
• 全球止血剂市场：氧化再生纤维素止血剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 垫片
• 颗粒
• 全球止血剂市场：复合止血剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 凝血酶-明胶复合物
• 凝血酶-胶原蛋白复合物
• 全球止血剂市场：明胶基止血剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 凝胶泡沫
• 明胶海绵
• 全球止血剂市场：胶原蛋白蛋白止血剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 胶原蛋白蛋白片
• 胶原蛋白蛋白粉

第七章 区域和国家分析

• 全球止血剂市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球止血剂市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 止血剂市场：竞争格局
• 止血剂市场：公司简介
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Medtronic PLC
• Hemostasis LLC
• Stryker Corporation
• Advanced Medical Solutions Group PLC
• Samyang Holdings Corporation
• Gelita Medical GmbH
• CryoLife Inc.
• CuraMedical BV
• Meril Life Sciences Pvt. Ltd.
• Beijing Datsing Bio-Tech Co. Ltd.
• Zhonghui Shengxi（Beijing）Medical Technology Co. Ltd.
• Biotemed Inc.
• Biom'up SA
• Shandong Foryou Medical Devices Co. Ltd.
• Z-Medica LLC

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年止血材料市场：提供新机会的国家
• 2029 年止血药市场：细分市场将带来新机会
• 止血剂市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emergency preparedness and pandemic response, global healthcare infrastructure development, growing demand for minimally invasive surgeries, expanding applications in various specialties, focus on biocompatibility. Major trends in the forecast period include product innovations, advancements in hemostatic technologies, focus on minimally invasive surgeries.

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a Lebanon-based professional organization for board-certified plastic surgeons, there was an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, both surgical and non-surgical procedures showed increases since the last survey (16.7% and 7.2% respectively). Therefore, an increase in surgical procedures is driving the growth of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In December 2022, Integra LifeSciences, a US-based medical technology company, acquired Surgical Innovation Associates for $150 million. This acquisition allows Integra LifeSciences Holding Corporation to enhance its product portfolio, expand its market reach, and strengthen its position in the medical technology sector. Surgical Innovation Associates is a US-based company specializing in providing advanced surgical technologies and solutions.

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats
• 2) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
• 3) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats
• 4) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
• Subsegments:
• 1) By Thrombin-Based Hemostats: Topical Thrombin; Lyophilized Thrombin
• 2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads; Granules
• 3) By Combination Hemostats: Thrombin And Gelatin Combinations; Thrombin And Collagen Combinations
• 4) By Gelatin-Based Hemostats: Gelfoam; Gelatin Sponge
• 5) By Collagen-Based Hemostats: Collagen Sheets; Collagen Powder
• Companies Mentioned: B. Braun Melsungen AG; Baxter International Inc.; Integra LifeSciences Corporation; Becton Dickinson and Company; Teleflex Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostats Market Characteristics

3. Hemostats Market Trends And Strategies

4. Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemostats Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hemostats Market Growth Rate Analysis
• 5.4. Global Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hemostats Total Addressable Market (TAM)

6. Hemostats Market Segmentation

• 6.1. Global Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombin-Based Hemostats
• Oxidized Regenerated Cellulose-Based Hemostats
• Combination Hemostats
• Gelatin-Based Hemostats
• Collagen-Based Hemostats
• 6.2. Global Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
• Other Product
• 6.3. Global Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Matrix And Gel Hemostats
• Sheet And Pad Hemostats
• Sponge Hemostats
• Powder Hemostats
• 6.4. Global Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Other Applications
• 6.5. Global Hemostats Market, Sub-Segmentation Of Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Thrombin
• Lyophilized Thrombin
• 6.6. Global Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pads
• Granules
• 6.7. Global Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombin And Gelatin Combinations
• Thrombin And Collagen Combinations
• 6.8. Global Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gelfoam
• Gelatin Sponge
• 6.9. Global Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collagen Sheets
• Collagen Powder

7. Hemostats Market Regional And Country Analysis

• 7.1. Global Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostats Market

• 8.1. Asia-Pacific Hemostats Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostats Market

• 9.1. China Hemostats Market Overview
• 9.2. China Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostats Market

• 10.1. India Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostats Market

• 11.1. Japan Hemostats Market Overview
• 11.2. Japan Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostats Market

• 12.1. Australia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostats Market

• 13.1. Indonesia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostats Market

• 14.1. South Korea Hemostats Market Overview
• 14.2. South Korea Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostats Market

• 15.1. Western Europe Hemostats Market Overview
• 15.2. Western Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostats Market

• 16.1. UK Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostats Market

• 17.1. Germany Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostats Market

• 18.1. France Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostats Market

• 19.1. Italy Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostats Market

• 20.1. Spain Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostats Market

• 21.1. Eastern Europe Hemostats Market Overview
• 21.2. Eastern Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostats Market

• 22.1. Russia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostats Market

• 23.1. North America Hemostats Market Overview
• 23.2. North America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostats Market

• 24.1. USA Hemostats Market Overview
• 24.2. USA Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostats Market

• 25.1. Canada Hemostats Market Overview
• 25.2. Canada Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostats Market

• 26.1. South America Hemostats Market Overview
• 26.2. South America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostats Market

• 27.1. Brazil Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostats Market

• 28.1. Middle East Hemostats Market Overview
• 28.2. Middle East Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostats Market

• 29.1. Africa Hemostats Market Overview
• 29.2. Africa Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostats Market Competitive Landscape And Company Profiles

• 30.1. Hemostats Market Competitive Landscape
• 30.2. Hemostats Market Company Profiles
  • 30.2.1. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Hemostats Market Other Major And Innovative Companies

• 31.1. Medtronic PLC
• 31.2. Hemostasis LLC
• 31.3. Stryker Corporation
• 31.4. Advanced Medical Solutions Group PLC
• 31.5. Samyang Holdings Corporation
• 31.6. Gelita Medical GmbH
• 31.7. CryoLife Inc.
• 31.8. CuraMedical B.V.
• 31.9. Meril Life Sciences Pvt. Ltd.
• 31.10. Beijing Datsing Bio-Tech Co. Ltd.
• 31.11. Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd.
• 31.12. Biotemed Inc.
• 31.13. Biom'up SA
• 31.14. Shandong Foryou Medical Devices Co. Ltd.
• 31.15. Z-Medica LLC

32. Global Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats Market

34. Recent Developments In The Hemostats Market

35. Hemostats Market High Potential Countries, Segments and Strategies

• 35.1 Hemostats Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hemostats Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hemostats Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer